{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T11:29:20Z","timestamp":1787311760929,"version":"build-2736575974"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,4,24]],"date-time":"2017-04-24T00:00:00Z","timestamp":1492992000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,4,24]],"date-time":"2017-04-24T00:00:00Z","timestamp":1492992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Mesenchymal stem cells (MSCs) represent promising resource of cells for regenerative medicine in neurological disorders. However, efficient and minimally invasive methods of MSCs delivery to the brain still have to be developed. Intra-arterial route is very promising, but MSCs are missing machinery for diapedesis through blood-brain barrier. Thus, here we have tested a mRNA-based method to induce transient expression of ITGA4, an adhesion molecule actively involved in cell extravasation. We observed that transfection with an ITGA4-mRNA construct bearing a conventional cap analogue (7-methylguanosine) failed to produce ITGA4 protein, but exogenous ITGA4-mRNA was detected in transfected MSCs. This indicates that not transfection, but rather translation being the major roadblock. Stabilization of ITGA4-mRNA with SSB proteins resulted in ITGA4 protein synthesis in HEK293 cells only, whereas in MSCs, satisfactory results were obtained only after using an anti-reverse-cap-analogue (ARCA). The presence of ITGA4 protein in MSCs was transient and lasted for up to 24\u2009h after transfection. Membranous location was confirmed by flow cytometry of viable non-permeabilized cells using anti-ITGA4 antibody. The mRNA-based expression of\n                    <jats:italic>itga4<\/jats:italic>\n                    transgene is potentially sufficient for diapedesis after intra-arterial delivery. To conclude, mRNA-based engineering of stem cells is a rapid\n                    <jats:strike>and<\/jats:strike>\n                    integration-free method and attractive from the perspective of potential future clinical application.\n                  <\/jats:p>","DOI":"10.1038\/s41598-017-01304-3","type":"journal-article","created":{"date-parts":[[2017,4,18]],"date-time":"2017-04-18T11:01:38Z","timestamp":1492513298000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Translation, but not transfection limits clinically relevant, exogenous mRNA based induction of alpha-4 integrin expression on human mesenchymal stem cells"],"prefix":"10.1038","volume":"7","author":[{"given":"Adam","family":"Nowakowski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Andrzejewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Boltze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska","family":"Nitzsche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-li","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jukka","family":"Jolkkonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Walczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Lukomska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miroslaw","family":"Janowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,4,24]]},"reference":[{"issue":"8","key":"1304_CR1","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1161\/STROKEAHA.114.007803","volume":"46","author":"M Janowski","year":"2015","unstructured":"Janowski, M., Wagner, D. C. & Boltze, J. Stem Cell-Based Tissue Replacement After Stroke: Factual Necessity or Notorious Fiction? Stroke. 46(8), 2354\u20132363, doi:10.1161\/STROKEAHA.114.007803 (2015).","journal-title":"Stroke."},{"issue":"1","key":"1304_CR2","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.3390\/ijms15011216","volume":"15","author":"SV Kabadi","year":"2014","unstructured":"Kabadi, S. V. & Faden, A. I. Neuroprotective strategies for traumatic brain injury: improving clinical translation. Int J Mol Sci. 15(1), 1216\u20131236, doi:10.3390\/ijms15011216 (2014).","journal-title":"Int J Mol Sci."},{"issue":"2","key":"1304_CR3","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1161\/STROKEAHA.113.003379","volume":"45","author":"SI Savitz","year":"2014","unstructured":"Savitz, S. I., Cramer, S. C. & Wechsler, L. STEPS 3 Consortium. Stem cells as an emerging paradigm in stroke 3: enhancing the development of clinical trials. Stroke. 45(2), 634\u2013639, doi:10.1161\/STROKEAHA.113.003379 (2014).","journal-title":"Stroke."},{"issue":"19","key":"1304_CR4","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1089\/scd.2015.0062","volume":"24","author":"A Nowakowski","year":"2015","unstructured":"Nowakowski, A., Walczak, P., Janowski, M. & Lukomska, B. Genetic Engineering of Mesenchymal Stem Cells for Regenerative Medicine. Stem Cells Dev. 24(19), 2219\u20132242, doi:10.1089\/scd.2015.0062 (2015).","journal-title":"Stem Cells Dev."},{"issue":"2","key":"1304_CR5","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.jconrel.2012.07.034","volume":"162","author":"B Huang","year":"2012","unstructured":"Huang, B., Tabata, Y. & Gao, J. Q. Mesenchymal stem cells as therapeutic agents and potential targeted gene delivery vehicle for brain diseases. J Control Release. 162(2), 464\u2013473, doi:10.1016\/j.jconrel.2012.07.034 (2012).","journal-title":"J Control Release."},{"issue":"1","key":"1304_CR6","doi-asserted-by":"publisher","first-page":"59","DOI":"10.5966\/sctm.2011-0017","volume":"1","author":"J Dom\u00ednguez-Bendala","year":"2012","unstructured":"Dom\u00ednguez-Bendala, J., Lanzoni, G., Inverardi, L. & Ricordi, C. Concise review: mesenchymal stem cells for diabetes. Stem Cells Transl Med. 1(1), 59\u201363, doi:10.5966\/sctm.2011-0017 (2012).","journal-title":"Stem Cells Transl Med."},{"issue":"2","key":"1304_CR7","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1007\/s12185-015-1920-z","volume":"103","author":"Y Miura","year":"2016","unstructured":"Miura, Y. Human bone marrow mesenchymal stromal\/stem cells: current clinical applications and potential for hematology. Int J Hematol. 103(2), 122\u20138, doi:10.1007\/s12185-015-1920-z (2016).","journal-title":"Int J Hematol."},{"issue":"10","key":"1304_CR8","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.3346\/jkms.2015.30.10.1405","volume":"30","author":"G Kim","year":"2015","unstructured":"Kim, G. et al. Therapeutic Effects of Mesenchymal Stem Cells for Patients with Chronic Liver Diseases: Systematic Review and Meta-analysis. J Korean Med Sci. 30(10), 1405\u201315, doi:10.3346\/jkms.2015.30.10.1405 (2015).","journal-title":"J Korean Med Sci."},{"issue":"1","key":"1304_CR9","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s10741-014-9435-x","volume":"20","author":"T Narita","year":"2015","unstructured":"Narita, T. & Suzuki, K. Bone marrow-derived mesenchymal stem cells for the treatment of heart failure. Heart Fail Rev. 20(1), 53\u201368, doi:10.1007\/s10741-014-9435-x (2015).","journal-title":"Heart Fail Rev."},{"issue":"6","key":"1304_CR10","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1002\/stem.430","volume":"28","author":"JS Lee","year":"2010","unstructured":"Lee, J. S. et al. A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke. Stem Cells. 28(6), 1099\u20131106, doi:10.1002\/stem.430 (2010).","journal-title":"Stem Cells."},{"issue":"6","key":"1304_CR11","doi-asserted-by":"publisher","first-page":"407","DOI":"10.2174\/157488812804484648","volume":"7","author":"MM Bonab","year":"2012","unstructured":"Bonab, M. M. et al. Autologous mesenchymal stem cell therapy in progressive multiple sclerosis: an open label study. Curr Stem Cell Res Ther. 7(6), 407\u201314, doi:10.2174\/157488812804484648 (2012).","journal-title":"Curr Stem Cell Res Ther."},{"issue":"12","key":"1304_CR12","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.biochi.2013.07.015","volume":"95","author":"H Kupcova-Skalnikova","year":"2013","unstructured":"Kupcova-Skalnikova, H. Proteomic techniques for characterisation of mesenchymal stem cell secretome. Biochimie. 95(12), 196\u2013211, doi:10.1016\/j.biochi.2013.07.015 (2013).","journal-title":"Biochimie."},{"key":"1304_CR13","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.neuroscience.2013.02.011","volume":"238","author":"JS Heo","year":"2013","unstructured":"Heo, J. S. et al. Neural transdifferentiation of human bone marrow mesenchymal stem cells on hydrophobic polymer-modified surface and therapeutic effects in an animal model of ischemic stroke. Neuroscience. 238, 305\u2013318, doi:10.1016\/j.neuroscience.2013.02.011 (2013).","journal-title":"Neuroscience."},{"issue":"3","key":"1304_CR14","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/pr.2012.71","volume":"72","author":"ES Kim","year":"2012","unstructured":"Kim, E. S. et al. Human umbilical cord blood-derived mesenchymal stem cell transplantation attenuates severe brain injury by permanent middle cerebral artery occlusion in newborn rats. Pediatr Res. 72(3), 277\u2013284, doi:10.1038\/pr.2012.71 (2012).","journal-title":"Pediatr Res."},{"issue":"1","key":"1304_CR15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/scrt159","volume":"4","author":"M Guti\u00e9rrez-Fern\u00e1ndez","year":"2013","unstructured":"Guti\u00e9rrez-Fern\u00e1ndez, M. et al. Effects of intravenous administration of allogenic bone marrow- and adipose tissue-derived mesenchymal stem cells on functional recovery and brain repair markers in experimental ischemic stroke. Stem Cell Res Ther. 4(1), 11, doi:10.1186\/scrt159 (2013).","journal-title":"Stem Cell Res Ther."},{"issue":"5","key":"1304_CR16","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1161\/STROKEAHA.107.502047","volume":"39","author":"P Walczak","year":"2008","unstructured":"Walczak, P. et al. Dual-modality monitoring of targeted intraarterial delivery of mesenchymal stem cells after transient ischemia. Stroke. 39(5), 1569\u20131574, doi:10.1161\/STROKEAHA.107.502047 (2008).","journal-title":"Stroke."},{"key":"1304_CR17","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.expneurol.2012.09.018","volume":"239","author":"B Mitkari","year":"2013","unstructured":"Mitkari, B. et al. Intra-arterial infusion of human bone-marrow derived mesenchymal stem cells results in transient localization in the brain after cerebral ischemia in rats. Exp Neurol. 239, 158\u2013162, doi:10.1016\/j.expneurol.2012.09.018 (2013).","journal-title":"Exp Neurol."},{"issue":"5","key":"1304_CR18","doi-asserted-by":"publisher","first-page":"e93735","DOI":"10.1371\/journal.pone.0093735","volume":"9","author":"DR Yavagal","year":"2014","unstructured":"Yavagal, D. R. et al. Efficacy and dose-dependent safety of intra-arterial delivery of mesenchymal stem cells in a rodent stroke model. PLoS One. 9(5), e93735, doi:10.1371\/journal.pone.0093735 (2014).","journal-title":"PLoS One."},{"issue":"6","key":"1304_CR19","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.3171\/2008.9.JNS08158","volume":"110","author":"MT Harting","year":"2009","unstructured":"Harting, M. T. et al. Intravenous mesenchymal stem cell therapy for traumatic brain injury. J Neurosurg. 110(6), 1189\u20131197, doi:10.3171\/2008.9.JNS08158 (2009).","journal-title":"J Neurosurg."},{"issue":"5","key":"1304_CR20","doi-asserted-by":"publisher","first-page":"997","DOI":"10.3727\/096368911X603611","volume":"21","author":"JH Ho","year":"2012","unstructured":"Ho, J. H. et al. Multiple intravenous transplantations of mesenchymal stem cells effectively restore long-term blood glucose homeostasis by hepatic engraftment and \u03b2-cell differentiation in streptozocin-induced diabetic mice. Cell Transplant. 21(5), 997\u20131009, doi:10.3727\/096368911X603611 (2012).","journal-title":"Cell Transplant."},{"issue":"11","key":"1304_CR21","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1002\/stem.533","volume":"28","author":"A Mohr","year":"2010","unstructured":"Mohr, A. et al. Targeting of XIAP combined with systemic mesenchymal stem cell-mediated delivery of sTRAIL ligand inhibits metastatic growth of pancreatic carcinoma cells. Stem Cells. 28(11), 2109\u201320, doi:10.1002\/stem.v28:11 (2010).","journal-title":"Stem Cells."},{"issue":"6","key":"1304_CR22","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1038\/jcbfm.2013.32","volume":"33","author":"M Janowski","year":"2013","unstructured":"Janowski, M. et al. Cell size and velocity of injection are major determinants of the safety of intracarotid stem cell transplantation. J Cereb Blood Flow Metab. 33(6), 921\u2013927, doi:10.1038\/jcbfm.2013.32 (2013).","journal-title":"J Cereb Blood Flow Metab."},{"key":"1304_CR23","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/scrt544","volume":"6","author":"L Cui","year":"2015","unstructured":"Cui, L. et al. The cerebral embolism evoked by intra-arterial delivery of allogeneic bone marrow mesenchymal stem cells in rats is related to cell dose and infusion velocity. Stem Cell Research & Therapy. 6, 11, doi:10.1186\/scrt544 (2015).","journal-title":"Stem Cell Research & Therapy."},{"issue":"14","key":"1304_CR24","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1212\/WNL.0000000000000278","volume":"82","author":"Q Vu","year":"2014","unstructured":"Vu, Q., Xie, K., Eckert, M., Zhao, W. & Cramer, S. C. Meta-analysis of preclinical studies of mesenchymal stromal cells for ischemic stroke. Neurology. 82(14), 1277\u20131286, doi:10.1212\/WNL.0000000000000278 (2014).","journal-title":"Neurology."},{"issue":"9","key":"1304_CR25","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/nri2156","volume":"7","author":"K Ley","year":"2007","unstructured":"Ley, K., Laudanna, C., Cybulsky, M. I. & Nourshargh, S. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol. 7(9), 678\u2013689, doi:10.1038\/nri2156 (2007).","journal-title":"Nat Rev Immunol."},{"issue":"1","key":"1304_CR26","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1148\/radiol.12112212","volume":"265","author":"M Gorelik","year":"2012","unstructured":"Gorelik, M. et al. Use of MR cell tracking to evaluate targeting of glial precursor cells to inflammatory tissue by exploiting the very late antigen-4 docking receptor. Radiology. 265(1), 175\u2013185, doi:10.1148\/radiol.12112212 (2012).","journal-title":"Radiology."},{"issue":"9","key":"1304_CR27","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/sj.cgt.7700827","volume":"12","author":"H Sato","year":"2005","unstructured":"Sato, H. et al. Epidermal growth factor receptor-transfected bone marrow stromal cells exhibit enhanced migratory response and therapeutic potential against murine brain tumors. Cancer Gene Ther. 12(9), 757\u2013768, doi:10.1038\/sj.cgt.7700827 (2005).","journal-title":"Cancer Gene Ther."},{"issue":"1","key":"1304_CR28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.55782\/ane-2013-1918","volume":"73","author":"A Nowakowski","year":"2013","unstructured":"Nowakowski, A., Andrzejewska, A., Janowski, M., Walczak, P. & Lukomska, B. Genetic engineering of stem cells for enhanced therapy. Acta Neurobiol Exp (Wars). 73(1), 1\u201318 (2013).","journal-title":"Acta Neurobiol Exp (Wars)."},{"issue":"8","key":"1304_CR29","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1111\/j.1440-1746.2012.07137.x","volume":"27","author":"JW Cho","year":"2012","unstructured":"Cho, J. W., Lee, C. Y. & Ko, Y. Therapeutic potential of mesenchymal stem cells overexpressing human forkhead box A2 gene in the regeneration of damaged liver tissues. J Gastroenterol Hepatol. 27(8), 1362\u20131370, doi:10.1111\/jgh.2012.27.issue-8 (2012).","journal-title":"J Gastroenterol Hepatol."},{"issue":"7","key":"1304_CR30","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1002\/jgm.2644","volume":"14","author":"S Elsler","year":"2012","unstructured":"Elsler, S. et al. Effective, safe, nonviral gene transfer to preserve the chondrogenic differentiation potential of human mesenchymal stem cells. J Gene Med. 14(7), 501\u2013511, doi:10.1002\/jgm.v14.7 (2012).","journal-title":"J Gene Med."},{"key":"1304_CR31","doi-asserted-by":"publisher","first-page":"735349","DOI":"10.1155\/2010\/735349","volume":"2010","author":"C Madeira","year":"2010","unstructured":"Madeira, C. et al. Nonviral gene delivery to mesenchymal stem cells using cationic liposomes for gene and cell therapy. J Biomed Biotechnol. 2010, 735349\u201312, doi:10.1155\/2010\/735349 (2010).","journal-title":"J Biomed Biotechnol."},{"issue":"27","key":"1304_CR32","doi-asserted-by":"publisher","first-page":"6485","DOI":"10.1016\/j.biomaterials.2012.05.040","volume":"33","author":"SJ Park","year":"2012","unstructured":"Park, S. J. & Na, K. The transfection efficiency of photosensitizer-induced gene delivery to human MSCs and internalization rates of eGFP and Runx2 genes. Biomaterials. 33(27), 6485\u20136494, doi:10.1016\/j.biomaterials.2012.05.040 (2012).","journal-title":"Biomaterials."},{"issue":"2","key":"1304_CR33","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1007\/BF02256058","volume":"10","author":"MK Majumdar","year":"2003","unstructured":"Majumdar, M. K. et al. Characterization and functionality of cell surface molecules on human mesenchymal stem cells. J Biomed Sci. 10(2), 228\u2013241 (2003). 68710.","journal-title":"J Biomed Sci."},{"issue":"14","key":"1304_CR34","doi-asserted-by":"publisher","first-page":"3917","DOI":"10.1096\/fj.07-8275com","volume":"21","author":"S Kumar","year":"2007","unstructured":"Kumar, S. & Ponnazhagan, S. Bone homing of mesenchymal stem cells by ectopic alpha 4 integrin expression. FASEB J. 21(14), 3917\u20133927, doi:10.1096\/fj.07-8275com (2007).","journal-title":"FASEB J."},{"issue":"3","key":"1304_CR35","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.jconrel.2010.07.124","volume":"147","author":"J Rejman","year":"2010","unstructured":"Rejman, J. et al. mRNA transfection of cervical carcinoma and mesenchymal stem cells mediated by cationic carriers. J Control Release. 147(3), 385\u2013391, doi:10.1016\/j.jconrel.2010.07.124 (2010).","journal-title":"J Control Release."},{"issue":"3","key":"1304_CR36","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1089\/ten.tec.2007.0359","volume":"14","author":"MF Ryser","year":"2008","unstructured":"Ryser, M. F. et al. mRNA transfection of CXCR4-GFP fusion\u2014simply generated by PCR-results in efficient migration of primary human mesenchymal stem cells. Tissue Eng Part C Methods. 14(3), 179\u2013184, doi:10.1089\/ten.tec.2007.0359 (2008).","journal-title":"Tissue Eng Part C Methods."},{"issue":"1","key":"1304_CR37","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s00232-010-9275-0","volume":"236","author":"JM Escoffre","year":"2010","unstructured":"Escoffre, J. M., Teissi\u00e9, J. & Rols, M. P. Gene transfer: how can the biological barriers be overcome? J Membr Biol. 236(1), 61\u201374, doi:10.1007\/s00232-010-9275-0 (2010).","journal-title":"J Membr Biol."},{"issue":"2","key":"1304_CR38","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1089\/cell.2011.0093","volume":"14","author":"S Ribeiro","year":"2012","unstructured":"Ribeiro, S. et al. Plasmid DNA size does affect nonviral gene delivery efficiency in stem cells. Cell Reprogram. 14(2), 130\u2013137, doi:10.1089\/cell.2011.0093 (2012).","journal-title":"Cell Reprogram."},{"issue":"5","key":"1304_CR39","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.addr.2004.12.008","volume":"57","author":"D Lechardeur","year":"2005","unstructured":"Lechardeur, D., Verkman, A. S. & Lukacs, G. L. Intracellular routing of plasmid DNA during non-viral gene transfer. Adv Drug Deliv Rev. 57(5), 755\u2013767, doi:10.1016\/j.addr.2004.12.008 (2005).","journal-title":"Adv Drug Deliv Rev."},{"issue":"14","key":"1304_CR40","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.1182\/blood-2013-04-495119","volume":"122","author":"O Levy","year":"2013","unstructured":"Levy, O. et al. mRNA-engineered mesenchymal stem cells for targeted delivery of interleukin-10 to sites of inflammation. Blood. 122(14), e23\u201332, doi:10.1182\/blood-2013-04-495119 (2013).","journal-title":"Blood."},{"issue":"1","key":"1304_CR41","doi-asserted-by":"publisher","first-page":"e55076","DOI":"10.1371\/journal.pone.0055076","volume":"8","author":"H Shi","year":"2013","unstructured":"Shi, H. et al. Systematic functional comparative analysis of four single-stranded DNA-binding proteins and their affection on viral RNA metabolism. PLoS One. 8(1), e55076, doi:10.1371\/journal.pone.0055076 (2013).","journal-title":"PLoS One."},{"issue":"10","key":"1304_CR42","first-page":"1486","volume":"7","author":"J Stepinski","year":"2001","unstructured":"Stepinski, J., Waddell, C., Stolarski, R., Darzynkiewicz, E. & Rhoads, R. E. Synthesis and properties of mRNAs containing the novel \u201canti-reverse\u201d cap analogs 7-methyl(3\u2032-O-methyl)GpppG and 7-methyl (3\u2032-deoxy)GpppG. RNA. 7(10), 1486\u20131495 (2001).","journal-title":"RNA."},{"key":"1304_CR43","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0076-6879(07)31011-2","volume":"431","author":"E Grudzien-Nogalska","year":"2007","unstructured":"Grudzien-Nogalska, E. et al. Synthesis of anti-reverse cap analogs (ARCAs) and their applications in mRNA translation and stability. Methods Enzymol. 431, 203\u2013227, doi:10.1016\/S0076-6879(07)31011-2 (2007).","journal-title":"Methods Enzymol."},{"issue":"5","key":"1304_CR44","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.tibs.2006.03.001","volume":"31","author":"E Simon","year":"2006","unstructured":"Simon, E., Camier, S. & Seraphin, B. New insights into the control of mRNA decapping. Trends Biochem Sci. 31(5), 241\u2013243, doi:10.1016\/j.tibs.2006.03.001 (2006).","journal-title":"Trends Biochem Sci."},{"issue":"6\u20137","key":"1304_CR45","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.bbagrm.2013.03.005","volume":"1829","author":"VK Nagarajan","year":"2013","unstructured":"Nagarajan, V. K., Jones, C. I., Newbury, S. F. & Green, P. J. XRN 5\u2032\u20133\u2032 exoribonucleases: structure, mechanisms and functions. Biochim Biophys Acta. 1829(6\u20137), 590\u2013603, doi:10.1016\/j.bbagrm.2013.03.005 (2013).","journal-title":"Biochim Biophys Acta."},{"issue":"10","key":"1304_CR46","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.tibs.2003.08.005","volume":"28","author":"P Nelson","year":"2003","unstructured":"Nelson, P., Kiriakidou, M., Sharma, A., Maniataki, E. & Mourelatos, Z. The microRNA world: small is mighty. Trends Biochem Sci. 28(10), 534\u2013540, doi:10.1016\/j.tibs.2003.08.005 (2003).","journal-title":"Trends Biochem Sci."},{"key":"1304_CR47","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.biomaterials.2015.11.005","volume":"77","author":"W Liao","year":"2016","unstructured":"Liao, W. et al. Mesenchymal stem cells engineered to express selectin ligands and IL-10 exert enhanced therapeutic efficacy in murine experimental autoimmune encephalomyelitis. Biomaterials. 77, 87\u201397, doi:10.1016\/j.biomaterials.2015.11.005 (2016).","journal-title":"Biomaterials."},{"issue":"11","key":"1304_CR48","doi-asserted-by":"publisher","first-page":"3315","DOI":"10.1002\/stem.2087","volume":"33","author":"S Wang","year":"2015","unstructured":"Wang, S. et al. Excess Integrins Cause Lung Entrapment of Mesenchymal Stem Cells. Stem Cells. 33(11), 3315\u20133326, doi:10.1002\/stem.2087 (2015).","journal-title":"Stem Cells."},{"issue":"1","key":"1304_CR49","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.stem.2009.05.003","volume":"5","author":"RH Lee","year":"2009","unstructured":"Lee, R. H. et al. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell. 5(1), 54\u201363, doi:10.1016\/j.stem.2009.05.003 (2009).","journal-title":"Cell Stem Cell."},{"key":"1304_CR50","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.brainres.2010.09.076","volume":"1367","author":"M von Wedel-Parlow","year":"2011","unstructured":"von Wedel-Parlow, M. et al. Neutrophils cross the BBB primarily on transcellular pathways: an in vitro study. Brain Res. 1367, 62\u201376, doi:10.1016\/j.brainres.2010.09.076 (2011).","journal-title":"Brain Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-01304-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-01304-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-01304-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T12:41:23Z","timestamp":1719146483000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-01304-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,24]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["1304"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-01304-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,24]]},"assertion":[{"value":"8 December 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"1103"}}